Japan Drug Makers Eschew Flu Vaccines In Favor Of Treatment
This article was originally published in PharmAsia News
Executive Summary
Japanese drug makers continue turning out flu treatments while their European counterparts concentrate on vaccines to prevent the diseases. Academic institutions are more likely to lead production of vaccines in Japan, with the exception of Denka Seiken, possibly hampering the country's ability to respond to a need for a sudden production increase. Major domestic drug makers in Japan have been reluctant to produce flu vaccines, possibly because they see few profits in doing so, as opposed to higher risks of side effects from the products. (Click here for more - a subscription may be required